AGP Picks
View all

Eureka State News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Eureka State News.

Press releases published on September 28, 2026

DVLT Investor Alert: Schall, Brown & Schwartz LLP Files Expanded Class Action Lawsuit Against Datavault AI, Inc. and Announces Opportunity for Investors to Lead Lawsuit
XTIA Investors Have Opportunity to Lead XTI Aerospace, Inc. Securities Fraud Lawsuit with SBS Law
BZAI Investors Have Opportunity to Lead Blaize Holdings, Inc. Securities Fraud Lawsuit with SBS Law
BABA Investors Have Opportunity to Lead Alibaba Group Holding Limited Securities Fraud Lawsuit with SBS Law
DEADLINE ALERT for RXT, BE, CAPR, and WSE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Steric Expands Beverage Processing Technology into RTD Production
Prometheus Security Group Global and Zignal Labs Selected for AFWERX SBIR Phase I Award
Gimlet Labs Adds Cerebras to Deliver Ultrafast AI Inference through Gimlet Cloud
Hyperion DeFi Supports D3’s Frontier Vault Launch, Bringing Internet Domain Priority Access to the Hyperliquid Ecosystem
Interlink Electronics to Participate in the Lytham Partners Fall 2026 Investor Conference
C1.ai launches C1 AppHub, a self-hosted platform for the apps your teams build
As iGaming Operators Add Social Features, GGWP Helps Them Grow and Keep Players
Pretzelmaker Brings Nashville Hot Flavor to Fall Snacking with New Frank’s RedHot® Pretzel Bites
Kratos Announces Promotion of Bill Wilson to C5ISR Systems Division President
ROTH to Host Emerging Nuclear Technology Conference on October 1 in New York City
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
Wedbush Expands Market Access with Launch of FutureSports Performance Index Products
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Eureka State News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.